Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06587256 · ClinicalTrials.gov registry record · Phase 2

Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.

A Phase 2 study of Snoring and Mild Obstructive Sleep Apnea, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT06587256: Recruiting Phase 2 study of Snoring and Mild Obstructive Sleep Apnea, sponsored by Johns Hopkins University.

NCT06587256 is a Phase 2 study of Snoring and Mild Obstructive Sleep Apnea that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, above the 40-participant average among 7 other Snoring trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06587256, a Phase 2 study of Snoring and Mild Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rather than a medical disorder, several studies indicate that snoring can disrupt sleep quality of the snorer, as well as the snorer's bed partner. Snoring also might lead to problems such as dry mouth, bad breath, dental problems, and even cardiovascular disease. Current treatments for snoring include lifestyle modifications such as weight loss, side-sleeping, and avoidance of evening alcohol intake. In some cases, invasive surgeries, dental devices, or even CPAP are recommended for snoring. These interventions have mixed effectiveness and may be difficult to use. It may be possible to treat snoring by fostering nasal breathing, while avoiding mouth-breathing during sleep. Breathing through the mouth reduces the airway diameter and contributes to snoring. Several studies show that nasal breathing can reduce snoring volume and improve airflow. Recent studies have shown that covering the mouth during sleep with adhesive patches or tape can improve snoring volume without adverse effects. However, these studies were performed in a small number of patients and did not fully measure the impact of the intervention on sleep quality, sleep architecture, or the experience of the bed partner, who is often the overlooked "victim" of the snoring. In this interventional study, the investigators will examine the safety and efficacy of mouth tape for snoring, focusing on subjective and objective snoring/breathing metrics of both the snorer and bed partner. Snoring is sometimes also a sign of obstructive sleep apnea (OSA). If OSA is ruled out with a sleep study, patients are considered to have "simple" snoring. When OSA is mild (apnea hypopnea index 15), treatments can include the same interventions as snoring (e.g. weight loss, avoidance of alcohol, side-sleeping) or can be more aggressively treated with devices such as continu

Primary Outcome

The patient will be asked about perceived snoring and sleep quality (score range 0-25, best=0, worst =25)

Interventions

  • DEVICE Mouth Tape

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-06-01
Est. Completion 2029-10
Phase Phase 2
Johns Hopkins University

1,448 total trials

What NCT06587256 shows while recruiting

NCT06587256 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 40-participant average among 7 other Snoring trials with a reported enrollment target (150% higher).

The record links to 2 conditions, with Snoring appearing as the primary indexed condition, and to 1 intervention - of which Mouth Tape is the first listed.

NCT06587256 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06587256 about?

NCT06587256 is a clinical study titled "Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.". Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rather than a medical disorder, several studies indicate that snoring can disrupt sleep quality of the snorer, as well as the snorer's bed partner...

What is the current status of trial NCT06587256?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2026-06-01. Estimated completion is 2029-10.

What conditions does trial NCT06587256 study?

This clinical trial studies the following conditions: Snoring, Mild Obstructive Sleep Apnea.

What interventions are being tested in trial NCT06587256?

The interventions under investigation include: Mouth Tape (DEVICE).

Who is sponsoring clinical trial NCT06587256?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06587256 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Snoring

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06587256, the US trial registry maintained by the National Library of Medicine. NCT06587256 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.